SHL Medical
Markus Puusepp has a diverse work experience. Markus has held several leadership positions at SHL Medical, including Chief Growth Officer and Chief Strategy Officer. Markus has also served as the Senior Director and Director of Corporate Ventures at the same company. In addition, they have been a Board Member at Spowdi, a Non Executive Board Member at QuiO, and the Chairman of the Board at Innovation Zed and Investest AB. Markus has also been a Board Member at Pharmaero ApS. Prior to these roles, they worked as a Senior Manager at White Peak Real Estate Investment, Special Accounts at Elekta, and as a Coordinator at the Swedish American Life Science Summit. Markus began their career as an Analyst at Scandinavian Health Partner.
Markus Puusepp completed their Master of Science (MSc) degree in Finance from Stockholm University, where they studied from 2004 to 2008. Prior to that, there is no available information about their education at KTH Royal Institute of Technology.
SHL Medical
8 followers
SHL Medical is a world-leading solutions provider of advanced drug delivery systems, such as autoinjectors. Driven by our company purpose – Enabling Patients’ Independence, we partner with leading pharma and biotech companies to pioneer the development of patient-centric solutions that support the enhancement of patients’ quality of life through self-injection systems as well as digital healthcare solutions. With over 5,000 employees located across our Switzerland, USA, Sweden and Taiwan offices, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development to final assembly, labeling, and packaging.